Profit

Looking to More R&D Spend: Dilip Shanghvi

PUBLISHED ON: March 25, 2015 | Duration: 28 min, 27 sec

  
loading..
The Ranbaxy merger will help increase R&D spend and the combined entity is looking forward to spend 6-7 per cent of turnover in research, said Dilip Shanghvi, the MD of Sun Pharma.
ALSO WATCH
Are Generic Drugs Safe?

................................ Advertisement ................................

................................ Advertisement ................................

Listen to the latest songs, only on JioSaavn.com